Differential impact of five coronary devices on plaque size: Insights from the ABSORB and SPIRIT trials

International Journal of Cardiology

Volumn 175, Issue 3, 2014, Pages 441-445

  García García, Héctor M ^a,b   Serruys, Patrick W ^a   Campos, Carlos M ^a,c   Onuma, Yoshinobu ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CARDIALYSIS   (Netherlands)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bioresorbable scaffolds; Coronary atherosclerosis; Stents

Indexed keywords

EVEROLIMUS; PACLITAXEL; POLYGLACTIN; METAL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BIORESORBABLE SCAFFOLD; CARDIOVASCULAR PARAMETERS; COMPARATIVE EFFECTIVENESS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY PLAQUE SIZE; CORONARY STENT; DRUG ELUTING STENT; EQUIPMENT DESIGN; FEMALE; FOLLOW UP; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MATERIAL COATING; MULTICENTER STUDY (TOPIC); NEOINTIMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; AGED; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; ECHOGRAPHY; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; STENT; TRENDS;

AGED; COHORT STUDIES; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METALS; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; STENTS; TREATMENT OUTCOME;

EID: 84905106877     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.06.026     Document Type: Article

References (15)

1. W. Wijns, P. Kolh, and N. Danchin et al. Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
2. H.M. Garcia-Garcia, V. Klauss, and N. Gonzalo et al. Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial intravascular ultrasound radiofrequency data analysis Int J Cardiovasc Imaging 28 2012 695 703
3. H.M. Garcia-Garcia, S. Garg, and S. Brugaletta et al. Evaluation of in-stent restenosis in the approach trial (assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history) Int J Cardiovasc Imaging 28 2012 455 465
4. P.W. Serruys, A.T. Ong, and J.J. Piek et al. A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: the spirit first trial EuroIntervention 1 2005 58 65
5. P.W. Serruys, P. Ruygrok, and J. Neuzner et al. A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the spirit "II" trial EuroIntervention 2 2006 286 294
6. J.A. Ormiston, P.W. Serruys, and E. Regar et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (absorb): a prospective open-label trial Lancet 371 2008 899 907
7. P.W. Serruys, J.A. Ormiston, and Y. Onuma et al. A bioabsorbable everolimus-eluting coronary stent system (absorb): 2-year outcomes and results from multiple imaging methods Lancet 373 2009 897 910
8. R. Hamers, N. Bruining, M. Knook, and M. Sabate A novel approach to quantitative analysis of intravascular ultrasound images Comput Cardiol 28 2008 589 592
9. A.V. Finn, F.D. Kolodgie, and J. Harnek et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents Circulation 112 2005 270 278
10. J. Aoki, A. Colombo, and D. Dudek et al. Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the taxus ii study Circulation 112 2005 3876 3883
11. M. Haude, R. Erbel, and P. Erne et al. Safety and performance of the drug-eluting absorbable metal scaffold (dreams) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man biosolve-i trial Lancet 381 2013 836 844
12. M.A. Mueller, F. Beutner, D. Teupser, U. Ceglarek, and J. Thiery Prevention of atherosclerosis by the mTOR inhibitor everolimus in ldlr -/- mice despite severe hypercholesterolemia Atherosclerosis 198 2008 39 48
13. S. Verheye, W. Martinet, and M.M. Kockx et al. Selective clearance of macrophages in atherosclerotic plaques by autophagy J Am Coll Cardiol 49 2007 706 715
14. S.E. Nissen, T. Tsunoda, and E.M. Tuzcu et al. Effect of recombinant apoa-i milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial JAMA 290 2003 2292 2300
15. S.J. Nicholls, C.M. Ballantyne, and P.J. Barter et al. Effect of two intensive statin regimens on progression of coronary disease N Engl J Med 365 2011 2078 2087